SEC Filing Details
Document Details
Form
Filing Date
Feb 14, 2022
Document Date
Feb 11, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Arrowhead Pharmaceuticals Inc.
Issuer
ARROWHEAD PHARMACEUTICALS, INC.
Filer
Anzalone Christopher Richard